Table 1.
Patient characteristics.
| Patient data |
<20% LASr at baseline
(N = 60) |
≥20% LASr at baseline
(N = 30) |
p-value |
|---|---|---|---|
| Male, n (%) | 30 (50.0) | 18 (60.0) | 0.502 |
| Age, years | 79.1 ± 6.7 | 77.4 ± 7.4 | 0.383 |
| Medical history | |||
| BMI, kg/m2 | 28.3 ± 5.9 | 27.7 ± 5.2 | 0.778 |
| Hypertension, n (%) | 55 (91.7) | 26 (86.7) | 0.474 |
| Diabetes mellitus, n (%) | 28 (46.7) | 9 (30.0) | 0.174 |
| Hyperlipidaemia, n (%) | 44 (73.3) | 21 (70.0) | 0.805 |
| COPD, n (%) | 14 (23.3) | 6 (20.0) | 0.720 |
| History of TIA/stroke, n (%) | 6 (10.0) | 2 (6.7) | 0.600 |
| Prior myocardial infarction, n (%) | 11 (18.3) | 7 (23.3) | 0.398 |
| PM/ICD/CRT, n (%) | 7 (11.7) | 2 (6.7) | 0.731 |
| Prior syncope, n (%) | 6 (10.0) | 7 (23.3) | 0.898 |
| Atrial fibrillation, n (%) | 21 (35.0) | 8 (26.7) | 0.116 |
| Medication | |||
| Oral anticoagulant therapy, n (%) | 20 (33.3) | 5 (16.7) | 0.096 |
| Single antiplatelet therapy, n (%) | 34 (56.7) | 12 (40.0) | 0.136 |
| Dual antiplatelet therapy, n (%) | 7 (11.7) | 13 (43.3) | <0.001 |
| Valve type, n (%) | 0.998 | ||
| Corevalve/Evolut R | 48 (80.0) | 24 (80.0) | |
| Portico | 12 (20.0) | 6 (20.0) |
BAV, Balloon aortic valvuloplasty; BMI, Body mass index; BSA, Body surface area; COPD, Chronic obstructive pulmonary disease; CRT, Cardiac resynchronization therapy; ICD, Implantable cardioverter-defibrillator; LASr, Left atrial peak reservoir strain; PM, Pacemaker; TIA, Transient ischemic attack Continuous variables are described as mean ± SD, or median and interquartile range, whereas categorical variables are represented as frequencies and percentage.